The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Nutex Health Inc’s stock clocked out at $159.95, down -1.18% from its previous closing price of $161.86. In other words, the price has decreased by -$1.18 from its previous closing price. On the day, 66434.0 shares were traded. NUTX stock price reached its highest trading level at $162.89 during the session, while it also had its lowest trading level at $156.53.
Ratios:
To gain a deeper understanding of NUTX’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.15 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.82. For the most recent quarter (mrq), Quick Ratio is recorded 2.26 and its Current Ratio is at 2.27. In the meantime, Its Debt-to-Equity ratio is 1.73 whereas as Long-Term Debt/Eq ratio is at 1.58.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on November 12, 2024, Reiterated its Buy rating but revised its target price to $50 from $45 previously.
On September 18, 2024, Maxim Group started tracking the stock assigning a Buy rating and target price of $45.
On February 22, 2023, Northland Capital started tracking the stock assigning a Outperform rating and target price of $3.Northland Capital initiated its Outperform rating on February 22, 2023, with a $3 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 08 ’25 when Bates Jon Christian bought 1,000 shares for $81.81 per share. The transaction valued at 81,810 led to the insider holds 4,888 shares of the business.
Bates Jon Christian bought 1,350 shares of NUTX for $28,970 on Aug 22 ’24. The Chief Financial Officer now owns 2,277 shares after completing the transaction at $21.46 per share. On Aug 19 ’24, another insider, DeTillio Joshua, who serves as the Chief Operating Officer of the company, bought 1,300 shares for $17.85 each. As a result, the insider paid 23,205 and bolstered with 4,233 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NUTX now has a Market Capitalization of 890230528 and an Enterprise Value of 1224634368. As of this moment, Nutex’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.44, and their Forward P/E ratio for the next fiscal year is 13.49. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.43 while its Price-to-Book (P/B) ratio in mrq is 4.49. Its current Enterprise Value per Revenue stands at 1.962 whereas that against EBITDA is 5.388.
Stock Price History:
The Beta on a monthly basis for NUTX is -0.02, which has changed by 21.7849 over the last 52 weeks, in comparison to a change of 0.09362543 over the same period for the S&P500. Over the past 52 weeks, NUTX has reached a high of $184.27, while it has fallen to a 52-week low of $4.16. The 50-Day Moving Average of the stock is 45.30%, while the 200-Day Moving Average is calculated to be 209.09%.
Shares Statistics:
It appears that NUTX traded 114.83K shares on average per day over the past three months and 184060 shares per day over the past ten days. A total of 5.53M shares are outstanding, with a floating share count of 3.55M. Insiders hold about 36.21% of the company’s shares, while institutions hold 18.26% stake in the company. Shares short for NUTX as of 1745971200 were 118725 with a Short Ratio of 1.03, compared to 1743379200 on 84591. Therefore, it implies a Short% of Shares Outstanding of 118725 and a Short% of Float of 3.3000000000000003.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
